| UniProt ID | CA043_HUMAN | |
|---|---|---|
| UniProt AC | Q9BWL3 | |
| Protein Name | Uncharacterized protein C1orf43 | |
| Gene Name | C1orf43 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 253 | |
| Subcellular Localization |
Membrane Single-pass membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MASGSNWLSGVNVVLVMAYGSLVFVLLFIFVKRQIMRFAMKSRRGPHVPVGHNAPKDLKEEIDIRLSRVQDIKYEPQLLADDDARLLQLETQGNQSCYNYLYRMKALDAIRTSEIPFHSEGRHPRSLMGKNFRSYLLDLRNTSTPFKGVRKALIDTLLDGYETARYGTGVFGQNEYLRYQEALSELATAVKARIGSSQRHHQSAAKDLTQSPEVSPTTIQVTYLPSSQKSKRAKHFLELKSFKDNYNTLESTL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 39 (in isoform 2) | Ubiquitination | - | 8.30 | 21906983 | |
| 39 (in isoform 4) | Ubiquitination | - | 8.30 | 21906983 | |
| 56 | Ubiquitination | PVGHNAPKDLKEEID CCCCCCCCCHHHHHH | 73.59 | - | |
| 59 | Sumoylation | HNAPKDLKEEIDIRL CCCCCCHHHHHHHCH | 64.53 | - | |
| 59 | Sumoylation | HNAPKDLKEEIDIRL CCCCCCHHHHHHHCH | 64.53 | - | |
| 59 | Ubiquitination | HNAPKDLKEEIDIRL CCCCCCHHHHHHHCH | 64.53 | - | |
| 73 | Ubiquitination | LSRVQDIKYEPQLLA HHHHHCCCCCCEEEC | 52.42 | 21906983 | |
| 73 (in isoform 1) | Ubiquitination | - | 52.42 | 21906983 | |
| 73 | Sumoylation | LSRVQDIKYEPQLLA HHHHHCCCCCCEEEC | 52.42 | - | |
| 73 | Sumoylation | LSRVQDIKYEPQLLA HHHHHCCCCCCEEEC | 52.42 | - | |
| 73 (in isoform 3) | Ubiquitination | - | 52.42 | 21906983 | |
| 73 (in isoform 5) | Ubiquitination | - | 52.42 | 21906983 | |
| 99 (in isoform 4) | Ubiquitination | - | 25.35 | 21906983 | |
| 105 | Ubiquitination | YNYLYRMKALDAIRT HHHHHHHHHHHHHHH | 36.48 | - | |
| 117 (in isoform 2) | Ubiquitination | - | 14.05 | 21906983 | |
| 130 | Ubiquitination | HPRSLMGKNFRSYLL CCHHHCCCCHHHHHH | 38.66 | - | |
| 133 (in isoform 5) | Ubiquitination | - | 33.51 | 21906983 | |
| 139 (in isoform 4) | Ubiquitination | - | 4.60 | 21906983 | |
| 147 | Ubiquitination | RNTSTPFKGVRKALI CCCCCCCHHHHHHHH | 58.67 | - | |
| 151 (in isoform 1) | Ubiquitination | - | 45.17 | 21906983 | |
| 151 | Ubiquitination | TPFKGVRKALIDTLL CCCHHHHHHHHHHHH | 45.17 | 21906983 | |
| 151 (in isoform 3) | Ubiquitination | - | 45.17 | 21906983 | |
| 157 (in isoform 2) | Ubiquitination | - | 3.49 | 21906983 | |
| 163 | Phosphorylation | TLLDGYETARYGTGV HHHCHHHHHHHCCCC | 14.14 | - | |
| 166 | Phosphorylation | DGYETARYGTGVFGQ CHHHHHHHCCCCCCH | 19.30 | 16094384 | |
| 173 (in isoform 5) | Ubiquitination | - | 28.28 | 21906983 | |
| 176 | Phosphorylation | GVFGQNEYLRYQEAL CCCCHHHHHHHHHHH | 12.20 | 25884760 | |
| 179 | Phosphorylation | GQNEYLRYQEALSEL CHHHHHHHHHHHHHH | 14.22 | - | |
| 191 | Ubiquitination | SELATAVKARIGSSQ HHHHHHHHHHHCCCH | 29.50 | 2190698 | |
| 191 (in isoform 1) | Ubiquitination | - | 29.50 | 21906983 | |
| 195 (in isoform 2) | Ubiquitination | - | 18.72 | - | |
| 206 | Ubiquitination | RHHQSAAKDLTQSPE HHHHHHHHHHHCCCC | 53.65 | - | |
| 209 | Phosphorylation | QSAAKDLTQSPEVSP HHHHHHHHCCCCCCC | 36.81 | 22199227 | |
| 211 | Phosphorylation | AAKDLTQSPEVSPTT HHHHHHCCCCCCCCE | 20.14 | 22199227 | |
| 215 | Phosphorylation | LTQSPEVSPTTIQVT HHCCCCCCCCEEEEE | 18.18 | 26657352 | |
| 217 | Phosphorylation | QSPEVSPTTIQVTYL CCCCCCCCEEEEEEC | 29.08 | 22199227 | |
| 218 | Phosphorylation | SPEVSPTTIQVTYLP CCCCCCCEEEEEECC | 16.88 | 27732954 | |
| 222 | Phosphorylation | SPTTIQVTYLPSSQK CCCEEEEEECCCCCC | 11.72 | 27732954 | |
| 223 | Phosphorylation | PTTIQVTYLPSSQKS CCEEEEEECCCCCCC | 20.12 | 27732954 | |
| 226 | Phosphorylation | IQVTYLPSSQKSKRA EEEEECCCCCCCHHH | 42.69 | 22199227 | |
| 227 | Phosphorylation | QVTYLPSSQKSKRAK EEEECCCCCCCHHHH | 39.42 | 25627689 | |
| 229 | Ubiquitination | TYLPSSQKSKRAKHF EECCCCCCCHHHHHH | 60.95 | - | |
| 234 | Ubiquitination | SQKSKRAKHFLELKS CCCCHHHHHHHHCHH | 38.63 | - | |
| 241 | Phosphorylation | KHFLELKSFKDNYNT HHHHHCHHHHHHHHH | 50.59 | 23312004 | |
| 243 | Ubiquitination | FLELKSFKDNYNTLE HHHCHHHHHHHHHHH | 52.75 | - | |
| 246 | Phosphorylation | LKSFKDNYNTLESTL CHHHHHHHHHHHHCC | 21.47 | 28796482 | |
| 248 | Phosphorylation | SFKDNYNTLESTL-- HHHHHHHHHHHCC-- | 22.88 | - | |
| 251 | Phosphorylation | DNYNTLESTL----- HHHHHHHHCC----- | 37.81 | 29214152 | |
| 252 | Phosphorylation | NYNTLESTL------ HHHHHHHCC------ | 27.41 | 28450419 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CA043_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CA043_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CA043_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TPM2_HUMAN | TPM2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-166, AND MASSSPECTROMETRY. | |